{
    "organizations": [],
    "uuid": "97b15a6ca3c25846ddceccf5f241da2672c83bbb",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indias-biocon-says-us-fda-complete/brief-indias-biocon-says-u-s-fda-completed-pre-approval-inspection-at-malaysia-unit-idUSFWN1QA179",
    "ord_in_thread": 0,
    "title": "BRIEF-India's Biocon ‍Says U.S. FDA Completed Pre-Approval Inspection At Malaysia Unit ​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 21 (Reuters) - Biocon Ltd:\n* ‍U.S. FDA COMPLETED PRE-APPROVAL INSPECTION AT MALAYSIA FACILITY AND ISSUED FORM 483 WITH 6 OBSERVATIONS​ Source text - bit.ly/2EUL56I Further company coverage:\n ",
    "published": "2018-02-21T11:20:00.000+02:00",
    "crawled": "2018-02-21T21:10:47.041+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "biocon",
        "ltd",
        "fda",
        "completed",
        "inspection",
        "malaysia",
        "facility",
        "issued",
        "form",
        "source",
        "text",
        "company",
        "coverage"
    ]
}